Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range
Aug 7, 2012 gilman alfred g Director Option Execute 15,000 15.80
Aug 6, 2012 brown michael s Director Sell 3,000 136.29
Aug 6, 2012 brown michael s Director Option Execute 3,000 23.84
Aug 1, 2012 powchik peter Officer Option Execute 14,990 15.64 - 21.92
Jul 30, 2012 terifay robert j Officer Automatic Sell 23,834 134.99 - 137.58
Jul 27, 2012 goldberg murray a Officer Disposition (Non Open Market) 600 n/a
Jul 27, 2012 terifay robert j Officer Automatic Sell 27,041 137.39
Jul 27, 2012 terifay robert j Officer Option Execute 50,875 16.80 - 21.92
Jul 26, 2012 powchik peter Officer Automatic Sell 7,019 130.40 - 131.07
Jul 26, 2012 sing george l Director Sell 5,000 135.00
Jul 26, 2012 sing george l Director Option Execute 5,000 18.80
Jul 25, 2012 powchik peter Officer Automatic Sell 7,981 126.76
Jul 25, 2012 powchik peter Officer Option Execute 15,000 16.80
Jul 24, 2012 vagelos p roy Officer Disposition (Non Open Market) 59,841 n/a
Jul 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,860 n/a
Jun 27, 2012 yancopoulos george Officer Acquisition (Non Open Market) 500,000 n/a
Jun 19, 2012 stahl neil Officer Automatic Sell 38,911 115.60 - 118.10
Jun 18, 2012 stahl neil Officer Automatic Sell 56,168 115.29
Jun 18, 2012 stahl neil Officer Option Execute 95,079 20.32
May 31, 2012 sing george l Director Sell 5,000 134.74 - 135.15
Showing 381-400 of 844 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)